Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Puffer fish biotoxin provides promising relief in cancer pain

05.02.2004


Recent results from a phase IIA clinical trial on the use of tetrodotoxin – a neurotoxin extracted from puffer fish – in patients with refractory cancer pain show extremely promising results.



The study, reported in the January/February issue of the Journal Supportive Oncology, details the findings from the open-label dose finding trial, showing that the majority of patients who received the novel analgesic experienced either a complete or partial response to the agent. Overall, 68% (17/25) patients responded, based on the primary study endpoint of a reduction in pain intensity of greater than 33%.

Tetrodotoxin is a non-addictive neurotoxin, originally used by Japanese researchers in the 1930s for the treatment of migraines, and menstrual cramps. The biotoxin was subsequently developed by Wex Technologies for the clinical treatment of heroin withdrawal. It works by blocking slow sodium channel nocicipetive pain fibres in a highly selective way.


"The identification of a medication that can help these patients who are not responding to current therapy is very promising," said Dr. Edward Sellars, President and Chief Operating Officer of Ventana Clinical Research Corporation, Toronto, Ontario, and Senior Medical Consultant to Vancouver based International Wex Technologies, the company developing tetrodotoxin. "These interim results indicate that a double-blind, controlled trial should be initiated," Dr. Sellers said. In fact, a Canadian phase III trial is being planned.

INTERNATIONAL WEX TECHNOLOGIES INC.
Don Evans
Corporate Communications
1-800-722-7549

Don Evans | EurekAlert!
Further information:
http://www.wextech.ca/pdf/JSO18_SCH_3C.pdf
http://www.wextech.ca/

More articles from Health and Medicine:

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

nachricht Research offers clues for improved influenza vaccine design
09.04.2018 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Scientists re-create brain neurons to study obesity and personalize treatment

20.04.2018 | Health and Medicine

Spider silk key to new bone-fixing composite

20.04.2018 | Materials Sciences

Clear as mud: Desiccation cracks help reveal the shape of water on Mars

20.04.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>